H.C. Wainwright lowered the firm’s price target on Rallybio (RLYB) to $5 from $6 and keeps a Buy rating on the shares following the Q3 report.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter